Pharma Journalist - Page 815 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

FDA accepts Intellipharmaceutics’ NDA for Rexista to treat moderate to severe pain

Momenta announces FDA warning letter to contracted Glatopa’s fill/finish manufacturer

Arix Bioscience raises £100m in IPO

Health Canada Approves Otsuka and Lundbeck’s REXULTI

Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery

Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility

Takeda acquires Ariad Pharmaceuticals

Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement for episil

Mayne Pharma Launches Butalbital Acetaminophen Tablets in The United States

X-Chem Expands Collaboration with Janssen in Inflammatory Diseases